glycine has been researched along with B16 Melanoma in 6 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Malignant melanoma is a highly aggressive tumor resistant to chemotherapy." | 5.46 | Poly(N-phenylglycine)-Based Nanoparticles as Highly Effective and Targeted Near-Infrared Photothermal Therapy/Photodynamic Therapeutic Agents for Malignant Melanoma. ( Guo, XL; Jiang, BP; Liang, H; Shen, XC; Wang, Y; Zhang, L; Zhu, Y, 2017) |
| "Physicochemical properties such as alkylating and carbamoylating activity and in vivo antimelanomic effects against B16 melanoma of the spin labeled (nitroxyl free radical containing) glycine nitrosourea (SLCNUgly) and its nonlabeled analogue (ChCNUgly), synthesized in our laboratory are studied and compared to those of antitumour drug 3-cyclohexyl-1-(2-chloroethyl)-1-nitrosourea (CCNU)." | 3.71 | Two glycine containing 2-chloroethylnitrosoureas--a comparative study on some physicochemical properties, in vivo antimelanomic effects and immunomodulatory properties. ( Dobreva, Z; Stanilova, S; Zhelev, Z; Zheleva, A, 2001) |
| "Malignant melanoma is a highly aggressive tumor resistant to chemotherapy." | 1.46 | Poly(N-phenylglycine)-Based Nanoparticles as Highly Effective and Targeted Near-Infrared Photothermal Therapy/Photodynamic Therapeutic Agents for Malignant Melanoma. ( Guo, XL; Jiang, BP; Liang, H; Shen, XC; Wang, Y; Zhang, L; Zhu, Y, 2017) |
| "Treatment with glycine (1-16 mM) for 72 h inhibited alpha-melanocyte stimulating hormone (alpha-MSH)-induced melanogenesis in a concentration-dependent manner without any effects on cell proliferation in B16F0 melanoma cells." | 1.34 | Glycine inhibits melanogenesis in vitro and causes hypopigmentation in vivo. ( Ishii, F; Ishikawa, M; Kawase, I, 2007) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (50.00) | 29.6817 |
| 2010's | 3 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, H | 1 |
| Liang, W | 1 |
| Zhu, Y | 2 |
| Guo, Z | 1 |
| Jian, J | 1 |
| Jiang, BP | 2 |
| Liang, H | 2 |
| Shen, XC | 2 |
| Garcia, MF | 1 |
| Zhang, X | 1 |
| Gallazzi, F | 1 |
| Fernandez, M | 1 |
| Moreno, M | 1 |
| Gambini, JP | 1 |
| Porcal, W | 1 |
| Cabral, P | 1 |
| Quinn, TP | 1 |
| Zhang, L | 1 |
| Guo, XL | 1 |
| Wang, Y | 1 |
| Ishikawa, M | 1 |
| Kawase, I | 1 |
| Ishii, F | 1 |
| Zheleva, A | 1 |
| Stanilova, S | 1 |
| Dobreva, Z | 1 |
| Zhelev, Z | 1 |
| Singer, JW | 1 |
| Bhatt, R | 1 |
| Tulinsky, J | 1 |
| Buhler, KR | 1 |
| Heasley, E | 1 |
| Klein, P | 1 |
| de Vries, P | 1 |
6 other studies available for glycine and B16 Melanoma
| Article | Year |
|---|---|
Supercharged fluorescent protein functionalized water-soluble poly(N-phenylglycine) nanoparticles for highly effective imaging-guided photothermal therapy.
Topics: Animals; Cell Line, Tumor; Drug Carriers; Glycine; Green Fluorescent Proteins; HeLa Cells; Humans; H | 2018 |
Evaluation of tricine and EDDA as Co-ligands for 99mTc-labeled HYNIC-MSH analogs for melanoma imaging.
Topics: alpha-MSH; Animals; Chelating Agents; Diagnostic Imaging; Edetic Acid; Glycine; Hydrazines; Ligands; | 2015 |
Poly(N-phenylglycine)-Based Nanoparticles as Highly Effective and Targeted Near-Infrared Photothermal Therapy/Photodynamic Therapeutic Agents for Malignant Melanoma.
Topics: Animals; Cell Death; Cell Line, Tumor; Glycine; Humans; Hyaluronic Acid; Hyperthermia, Induced; Infr | 2017 |
Glycine inhibits melanogenesis in vitro and causes hypopigmentation in vivo.
Topics: alpha-MSH; Amino Acids; Animals; Antioxidants; Cell Line, Tumor; Dose-Response Relationship, Drug; F | 2007 |
Two glycine containing 2-chloroethylnitrosoureas--a comparative study on some physicochemical properties, in vivo antimelanomic effects and immunomodulatory properties.
Topics: Adjuvants, Immunologic; Animals; Antineoplastic Agents; Glycine; Lomustine; Male; Melanoma, Experime | 2001 |
Water-soluble poly-(L-glutamic acid)-Gly-camptothecin conjugates enhance camptothecin stability and efficacy in vivo.
Topics: Animals; Antineoplastic Agents, Phytogenic; Camptothecin; Glycine; HT29 Cells; Humans; Melanoma, Exp | 2001 |